TY - JOUR
T1 - Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease
T2 - Clinical score and internal globus pallidus activity
AU - Stefani, A.
AU - Stanzione, P.
AU - Bassi, A.
AU - Mazzone, P.
AU - Vangelista, T.
AU - Bernardi, G.
PY - 1997
Y1 - 1997
N2 - We analysed the firing activity of internal globus pallidus cells in two Parkinson's disease patients undergoing stereotaxic surgery. Both patients showed an advanced rigid-akinetic syndrome with disabling levodopa induced dyskinesias. Apomorphine, intraoperatively administered at doses (1-2 mg) inducing a short but clear clinical improvement without involuntary movements, reduced the pallidal discharge rate by > 50% in both patients. An higher apomorphine dose (2.5 mg), tested in one hemisphere, blocked the firing activity with a time course independent from the occurrence of dyskinesias. These finding suggest that the reduction of internal pallidus excitability is one of the mechanisms underlying the efficacy of dopaminergic therapy, but also that changes in other basal ganglia stations are likely to be involved in dyskinesias.
AB - We analysed the firing activity of internal globus pallidus cells in two Parkinson's disease patients undergoing stereotaxic surgery. Both patients showed an advanced rigid-akinetic syndrome with disabling levodopa induced dyskinesias. Apomorphine, intraoperatively administered at doses (1-2 mg) inducing a short but clear clinical improvement without involuntary movements, reduced the pallidal discharge rate by > 50% in both patients. An higher apomorphine dose (2.5 mg), tested in one hemisphere, blocked the firing activity with a time course independent from the occurrence of dyskinesias. These finding suggest that the reduction of internal pallidus excitability is one of the mechanisms underlying the efficacy of dopaminergic therapy, but also that changes in other basal ganglia stations are likely to be involved in dyskinesias.
KW - Deep brain stimulation
KW - Dopamine
KW - Dyskinesias
KW - Parkinson's basal ganglia
UR - http://www.scopus.com/inward/record.url?scp=0030700714&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030700714&partnerID=8YFLogxK
M3 - Article
C2 - 9451721
AN - SCOPUS:0030700714
SN - 0375-9245
VL - 104
SP - 895
EP - 904
JO - Journal of Neuro-Visceral Relations
JF - Journal of Neuro-Visceral Relations
IS - 8-9
ER -